Publicacións en colaboración con investigadores/as de Mary Crowley Cancer Research Center (1)

2023

  1. A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer

    Clinical Cancer Research, Vol. 29, Núm. 17, pp. 3292-3300